About 15 researchers in the Division of Biotechnology and Pharmaceutical Research at the National Health Research Institutes (NHRI), fired with enthusiasm for the development of new pharmaceuticals, made the decision to found TaiGen in 2001. Taking the helm as CEO was Hsu Ming-chu, a veteran of the pharmaceuticals industry who had previously held the position of research director for oncology and virology at Hoffmann-La Roche, USA, for 11 years.
2001 年，國家衛生研究院生物技術與藥物研究組內一群對新藥研發抱持高度熱忱的研究同仁約 15 位，選擇投入業界、創辦了太景生技，由製藥經驗豐富、曾任羅氏大藥廠病毒與腫瘤藥物研究總監長達 11 年的許明珠出任執行長。